Utilizing Intra- and Peritumoral Radiomics to Assess Ambiguous HER2 Status in Breast Cancer via Contrast-Enhanced Mammography - Quiz - MDSpire

Utilizing Intra- and Peritumoral Radiomics to Assess Ambiguous HER2 Status in Breast Cancer via Contrast-Enhanced Mammography

  • By

  • Cong Xu

  • Juan Qiu

  • Shijie Zhang

  • Yuqian Chen

  • Xiaodong Wang

  • Haicheng Zhang

  • Qi Wang

  • Tongpeng Chu

  • Ziyin Li

  • Peng Lu

  • Haizhu Xie

  • Heng Ma

  • Nina Qu

  • Ning Mao

  • Jing Liu

  • Runpeng Chen

  • Jing Gao

  • April 29, 2026

  • 0 min

Share

Original Source(s)

Utilizing Intra- and Peritumoral Radiomics to Assess Ambiguous HER2 Status in Breast Cancer via Contrast-Enhanced Mammography

  • by Cong Xu, Juan Qiu, Shijie Zhang, Yuqian Chen, Xiaodong Wang, Haicheng Zhang, Qi Wang, Tongpeng Chu, Ziyin Li, Peng Lu, Haizhu Xie, Heng Ma, Nina Qu, Ning Mao, Jing Liu, Runpeng Chen, Jing Gao

  • April 29, 2026

Related Content

Glioblastoma, IDH-wildtype, with a novel MEF2D-NTRK1 gene fusion: a case report

Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study

Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment